From the perspective of neuroinflammation, eltoprazine reduced the L‐DOPA‐induced upregulation of immediate‐early gene zif‐268 in striatum, delayed the onset of dyskinesia, and reserved the efficacy of L‐dopa.44, 45. This evidence concerns the gene EGR1 and Dyskinesia.